Company: PETVW
Filing Date: 2025-06-16
Form Type: 8-K
Source: 0001641172-25-015235
Chunk: 0

Company: PetVivo Holdings, Inc.
Filing Date: 2025-06-16
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item      Unregistered                 

On
June 16, 2025, PetVivo Holdings, Inc., including its wholly-owned subsidiary PetVivo Animal Health, Inc., (collectively the “ Company”,
“we” and “us”) received Two Hundred Thousand Dollars ($200,000) pursuant to the partial exercise of a purchase
option (“ Purchase Option”) granted to the investor as part of an offering to receive Five Million Dollars ($5,000,000) of
equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock (“ Shares”) (the “ Offering”);
pursuant to the Offering, the purchase price for one (1) Share of Series B Convertible Preferred Stock is One Dollar ($1.00) and the
conversion rate is one (1) Share of Series B Convertible Preferred Stock for one (1) share of Company common stock. The Company has previously
received an aggregate total of Eight Hundred Thousand Dollars ($800,000) of the Offering prior to the current Purchase Option exercise.
An additional Four Million Dollars ($4,000,000) of the Purchase Option remains for exercise at the investor’s discretion pursuant
to the terms and conditions of the subscription agreement of the Offering (“ Subscription Agreement”). It is anticipated the
remaining Four Million Dollars ($4,000,000) of the Purchase Option will be received by the Company on or before June 26, 2025.

The
Offering was conducted pursuant to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended
(“ Securities Act”). The investor entered into the Subscription Agreement with the Company and represented in writing that
he, she, or it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act)
and acquired the securities for his, her or its own account for investment purposes and any subsequent transfer or sales of these securities
will be in accordance with the Securities Act or exempt from registration under the Securities Act. The shares of Series B Preferred
Stock will be “restricted securities” under Rule 144 of the Securities Act, and certificates representing the foregoing will
bear a Rule 144 restrictive legend.

The
form of Subscription Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K, respectively, and the description in this
Current Report on Form 8-K of terms of Subscription Agreement are qualified in their entirety by reference to such